Watchful Waiting OK in Diabetic Macular Edema With Good Vision

New trial suggests no difference in risk for vision loss over 2 years with aflibercept, laser treatment, or observation; experts stress importance of adherence to follow-up and tight glycemic control.
Medscape Medical News

Full Story →